Relevance of obesity and overweight to salivary and plasma proteomes of human young adults from Brazil / Relevância da obesidade e sobrepeso para os proteomas salivares e plasmáticos de adultos jovens humanos do Brasil
DOI:
https://doi.org/10.34117/bjdv8n2-363Keywords:
salivary proteome, plasma proteome, obesity, overweight, bioindicators.Abstract
Obesity is a chronic condition related to multiple comorbidities such as hypertension, type 2 diabetes, periodontal and cardiovascular diseases. Obesity can lead to a metabolic change, creating a prolonged and low-intensity inflammatory process. This study aims to analyze the plasma and saliva proteomes of young adults with obesity and overweight comparing to normal weight individuals, to reveal if the rise on body mass influences the proteomic profiles. The reported population consisted of 18 students and/or employees of Rio de Janeiro State, Brazil, aged between 18 and 35 years. Individuals were categorized according to their anthropometric measures in the Normal Weight, Overweight and Obese groups. Proteomic characterization was assessed by quantitative Mass Spectrometry (LC-ESI Q/TOF). In addition, cytokines were identified by Multiplex analysis. A total of 118 human proteins from saliva and plasma were identified, including 7 that were common between both fluids. The salivary and plasma proteomes seemed to be related to the body mass index, once the three groups showed distinct proteome profiles. Altogether 49 proteins presented different abundances between the obese, overweight, and normal weight individuals. The main functional category modified in both fluids was the immune response. Most of the modified proteins were previously reported as related to inflammatory diseases, such as cardiovascular diseases and Type 2 Diabetes Mellitus, in particular alpha-1 antitrypsin, C3 complement, alpha-1-antichymotrypsin, zinc-alpha2-glycoprotein, apolipoprotein AI and lysozyme, that could be tested to possible use as early biomarkers of obesity comorbidities.
References
Agra RM, Varela-Román A, González-Ferreiro R, Viñuela JE, Castro-Pais A, Fernández-Trasancos Á, et al. 2017. Orosomucoid as prognosis factor associated with inflammation in acute or nutritional status in chronic heart failure. Int J Cardiol 228: 488–494.
Akil L, Ahmad HA. 2011. Relationships between Obesity and Cardiovascular Diseases in Four Southern States and Colorado. J Health Care Poor Underserved 22: 61–72.
Andersen CJ, Murphy KE, Fernandez ML. 2016. Impact of Obesity and Metabolic Syndrome on Immunity. Adv Nutr 7: 66–75.
Apha-1-antichymotrypsin <https://www.uniprot.org/uniprot/P01011> Acessed Jan 15 2021.
Apolipoproteins [https://www.mabtech.com/knowledge-center/applied-research/apolipoproteins], Acessed Nov 6 2021.
Bao X, Xia Y, Zhang Q, Wu HM, Du HM, Liu L, et al. 2016. Elevated serum complement C3 levels are related to the development of prediabetes in an adult population: the Tianjin Chronic Low-Grade Systematic Inflammation and Health Cohort Study. Diabet Med 33: 446–453.
Berger M, de Moraes JA, Beys-da-Silva WO, Santi L, Terraciano PB, Driemeier D, et al. 2019. Renal and vascular effects of kallikrein inhibition in a model of Lonomia obliqua venom-induced acute kidney injury. PLoS Negl Trop Dis 13(2):e0007197.
Bossa AS, Salemi VMC, Ribeiro SP, Rosa DS, Ferreira LRP, Ferreira SC, et al. 2014. Plasma Cytokine Profile in Tropical Endomyocardial Fibrosis: Predominance of TNF-a, IL-4 and IL-10. Shoukry NH, editor. PLoS One 9: e108984.
Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254.
Brener A, Lebenthal Y, Interator H, Horesh O, Leshem A, Weintrob N, et al. 2018. Long-term safety of α-1 antitrypsin therapy in children and adolescents with Type 1 diabetes. Immunotherapy 10: 1137–1148.
Callewaert L, Michiels CW. 2010. Lysozymes in the animal kingdom. J Biosci. ;35: ,127–160.
Carnielli CM, Macedo CCS, De Rossi T, Granato DC, Rivera C, Domingues RR, et al. 2018. Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer. Nat Commun 9: 3598.
Clarke R, Valdes-Marquez E, Hill M, Gordon J, Farrall M, Hamsten A, et al. 2018. Plasma cytokines and risk of coronary heart disease in the PROCARDIS study. Open Hear 5: e000807.
Cox, J. & Mann, M. 2008. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 26: 1367–1372.
Dadu RT, Dodge R, Nambi V, Virani SS, Hoogeveen RC, Smith NL, et al. 2013. Ceruloplasmin and Heart Failure in the Atherosclerosis Risk in Communities Study. Circ Hear Fail 6: 936–943. CIRCHEARTFAILURE.113.000270
de O Santos E, Alves N, Dias GM, Mazotto AM, Vermelho A, Vora GJ, et al. 2011. Genomic and proteomic analyses of the coral pathogen Vibrio coralliilyticus reveal a diverse virulence repertoire. ISME J 5: 1471–1483.
Ghazanfar S, Fatima I, Aslam M, Musharraf SG, Sherman NE, Moskaluk C, et al. 2017. Identification of actin beta-like 2 (ACTBL2) as novel, upregulated protein in colorectal cancer. J Proteomics 152: 33–40.
Gómez-Cardona EE, Hernández-Domínguez EE, Velarde-Salcedo AJ, Pacheco A-B-, Diaz-Gois A, De León-Rodríguez A, et al. 2017. 2D-DIGE as a strategy to identify serum biomarkers in Mexican patients with Type-2 diabetes with different body mass index. Sci Rep 7: 46536.
Gonçalves LDR, Soares MR, Nogueira FCS, Garcia C, Camisasca DR, Domont G, et al. 2010. Comparative proteomic analysis of whole saliva from chronic periodontitis patients. J Proteomics 73: 1334–1341.
Gram M, Sveinsdottir S, Ruscher K, Hansson SR, Cinthio M, Åkerström B, et al. Hemoglobin induces inflammation after preterm intraventricular hemorrhage by methemoglobin formation. J Neuroinflammation. 2013;10: 867.
Gregor MF, Hotamisligil GS. 2011. Inflammatory Mechanisms in Obesity. Annu Rev Immunol 29: 415–445.
Kim M, Cai Q, Oh Y. 2018. Therapeutic potential of alpha-1 antitrypsin in human disease. Ann Pediatr Endocrinol Metab. 23: 131–135.
Kim SW, Choi J-W, Yun JW, Chung I-S, Cho HC, Song S-E, et al. 2019. Proteomics approach to identify serum biomarkers associated with the progression of diabetes in Korean patients with abdominal obesity. PLoS ONE 14(9): e0222032
Kiseleva OI, Arzumanian VA, Poverennaya EV, et al. 2021. Does Proteomic Mirror Reflect Clinical Characteristics of Obesity?. J Pers Med 11(2):64. doi:10.3390/jpm11020064
Kota SK, Pernicone E, Leaf DE, Stillman IE, Waikar SS, Kota SB. 2017. BPI Fold-Containing Family A Member 2/Parotid Secretory Protein Is an Early Biomarker of AKI. J Am Soc Nephrol 28: 3473–3478.
Lee S-G, Rim JH, Kim J-H. 2015. Association of hemoglobin levels with blood pressure and hypertension in a large population-based study: the Korea National Health and Nutrition Examination Surveys 2008–2011. Clin Chim Acta 438: 12–18.
Luz CM, Boyles M, Lotsch PF, Pereira MR, Tutumi HR, Santos EO, Martins NB, Himly M, Sommer A, Foissner I, Duschl A, Granjeiro JM, Leite PE. 2017. Poly-lactic acid nanoparticles (PLA-NP) promote physiological modifications in lung epithelial cells and are internalized by clathrin-coated pits and lipid rafts. Journal of Nanobiotechnology, v. 15, p. 11-28.
Marteijn JA, Lans H, Vermeulen W, Hoeijmakers JHJ. 2014. Understanding nucleotide excision repair and its roles in cancer and ageing. Nat Rev Mol Cell Biol. 15: 465–481.
Martin-Rojas T, Mourino-Alvarez L, Gil-Dones F, de la Cuesta F, Rosello-Lleti E, Laborde CM, et al. 2017. A clinical perspective on the utility of alpha 1 antichymotrypsin for the early diagnosis of calcific aortic stenosis. Clin Proteomics 14: 12.
Melander O, Modrego J, Zamorano‐León JJ, Santos‐Sancho JM, Lahera V, López‐Farré AJ. 2015. New circulating biomarkers for predicting cardiovascular death in healthy population. J Cell Mol Med 19: 2489–2499.
Nagampalli RSK, Quesñay JEN, Adamoski D, Islam Z, Birch J, Sebinelli HG, et al. Human mitochondrial pyruvate carrier 2 as an autonomous membrane transporter. Sci Rep. 2018;8: 3510.
Obesity and overweight. (2021) [http://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight], Acessed Nov 06 2021.
Ornitz DM, Itoh N. 2015. The Fibroblast Growth Factor signaling pathway. Wiley Interdiscip Rev Dev Biol 4: 215–266.
Phillips CM, Perry IJ. 2013. Does Inflammation Determine Metabolic Health Status in Obese and Nonobese Adults? J Clin Endocrinol Metab 98: E1610–E1619.
Rankin SM, Conroy DM, Williams TJ. 2000. Eotaxin and eosinophil recruitment: implications for human disease. Mol Med Today 6: 20–27.
Salcedo R, Young HA, Ponce ML, Ward JM, Kleinman HK, Murphy WJ, et al. 2001. Eotaxin (CCL11) Induces In Vivo Angiogenic Responses by Human CCR3 + Endothelial Cells. J Immunol 166: 7571–7578.
Schöttl T, Pachl F, Giesbertz P, Daniel H, Kuster B, Fromme T, Klingenspor M. 2020. Proteomic and Metabolite Profiling Reveals Profound Structural and Metabolic Reorganization of Adipocyte Mitochondria in Obesity. Obesity (Silver Spring) 3:590-600.
Shecaira TP, Viana AO, Barboza CA, Bueno GC, Costa DI. Influence of obesity on cognitive performance and hemodynamic response to mental stress test. Braz. J. of Develop., Curitiba, v. 6, n.12, p. 93755-93770 dec. 2020.
Silva-Boghossian CM, Colombo AP V., Tanaka M, Rayo C, Xiao Y, Siqueira WL. Quantitative Proteomic Analysis of Gingival Crevicular Fluid in Different Periodontal Conditions. PLoS One. 2013.
Sung K-C, Ryu S, Wild SH, Byrne CD. 2015. An increased high-density lipoprotein cholesterol/apolipoprotein A-I ratio is associated with increased cardiovascular and all-cause mortality. Heart 101: 553–558.
Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, et al. 2013. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 187: 347–365.
Wang Q, Li X, Ren S, Cheng N, Zhao M, Zhang Y, et al. 2015. Serum Levels of the Cancer-Testis Antigen POTEE and Its Clinical Significance in Non-Small-Cell Lung Cancer. Coleman WB, editor. PLoS One 10: e0122792.
Wang W, Blackett P, Khan S, Lee E. 2017. Apolipoproteins A-I, B, and C-III and Obesity in Young Adult Cherokee. J Lipids 1–7.
Yi L, Hao M, Lu T, Lin G, Chen L, Gao M, et al. 2016. Increased Kappa/Lambda Hybrid Antibody in Serum Is a Novel Biomarker Related to Disease Activity and Inflammation in Rheumatoid Arthritis. Mediators Inflammation 1–10.
